Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection

Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tejram Sahu, Ella J. Gehrke, Yevel Flores-Garcia, Godfree Mlambo, Julia D. Romano, Isabelle Coppens
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:432db3d909be41fbba6bddb8eb40f52c
record_format dspace
spelling oai:doaj.org-article:432db3d909be41fbba6bddb8eb40f52c2021-12-02T16:27:59ZChemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection10.1038/s41541-021-00360-12059-0105https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00360-1https://doaj.org/toc/2059-0105Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific autophagy mutant of Plasmodium berghei (ATG8 overexpressor), when used as a live vaccine under a CVac regimen, provides superior long-lasting protection, in both inbred and outbred mice, as compared to WT-CVac. Uniquely, the protection elicited by this mutant is predominantly dependent on a CD8+ T-cell response through an IFN-γ-independent mechanism and is associated with a stable population of antigen-experienced CD8+ T cells. Jointly, our findings support the exploitation of liver-stage mutants as vaccines under a CVac protocol. This vaccination strategy is also a powerful model to study the mechanisms of protective immunity and discover new protective antigens.Tejram SahuElla J. GehrkeYevel Flores-GarciaGodfree MlamboJulia D. RomanoIsabelle CoppensNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Tejram Sahu
Ella J. Gehrke
Yevel Flores-Garcia
Godfree Mlambo
Julia D. Romano
Isabelle Coppens
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
description Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific autophagy mutant of Plasmodium berghei (ATG8 overexpressor), when used as a live vaccine under a CVac regimen, provides superior long-lasting protection, in both inbred and outbred mice, as compared to WT-CVac. Uniquely, the protection elicited by this mutant is predominantly dependent on a CD8+ T-cell response through an IFN-γ-independent mechanism and is associated with a stable population of antigen-experienced CD8+ T cells. Jointly, our findings support the exploitation of liver-stage mutants as vaccines under a CVac protocol. This vaccination strategy is also a powerful model to study the mechanisms of protective immunity and discover new protective antigens.
format article
author Tejram Sahu
Ella J. Gehrke
Yevel Flores-Garcia
Godfree Mlambo
Julia D. Romano
Isabelle Coppens
author_facet Tejram Sahu
Ella J. Gehrke
Yevel Flores-Garcia
Godfree Mlambo
Julia D. Romano
Isabelle Coppens
author_sort Tejram Sahu
title Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
title_short Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
title_full Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
title_fullStr Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
title_full_unstemmed Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
title_sort chemoprophylaxis vaccination with a plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c
work_keys_str_mv AT tejramsahu chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
AT ellajgehrke chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
AT yevelfloresgarcia chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
AT godfreemlambo chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
AT juliadromano chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
AT isabellecoppens chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection
_version_ 1718383925997338624